Method for treating cancer using galactose-specific lectins

Details Method for treating cancer using galactose-specific lectins Method for treating cancer using galactose-specific lectins

1982-02-01

1985-01-29

Rosen, Sam

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

424195, A61K 3748, A61K 3578

Patent

active

044965397

ABSTRACT:
This invention discloses a method of using galactose-binding lectins, such as Ricinus communis agglutinin I (RCA.sub.I), to kill cancer cells. RCA.sub.I has been found to severely weaken certain types of cancer cells, such as bladder carcinoma. This weakening can kill substantial numbers of cancer cells. In addition, it is possible to attach RCA.sub.I to other substances which impose stress on cells, such as cytotoxic drugs or enzymes that catalyze exothermic reactions, which can kill weakened cancer cells.

REFERENCES:
patent: 4132600 (1979-01-01), Plotkin et al.
Gontas et al.-J. of Cell Biology, vol. 52 (2 part 1) 1973, pp. 436-443.
Robbins et al.-Chem. Abst., vol. 87 (1977), p. 47981g.
Saltvedt-Chem. Abst., vol. 86 (1977), p. 38388w.
Glimelius et al.-Int. J. Cancer, vol. 14 (1974), pp. 314-325.
Kaneko et al.-Biochem. & Biophys. Res. Comm., vol. 50, No. 4 (1973), pp. 1087-1094.
Nicolson-Symposium Biol. & Chem. Eucaryot. Cell Surface, (1974), pp. 103-124.
Schlepper-Schafer-European J. of Cell Biology, vol. 25 (1981), pp. 95-102.
Onozaki et al.-Biochem. & Biophysical Res. Comm., vol. 48, No. 4 (1972), pp. 783-788.
Nicolson et al.-Chem. Abst., vol. 91 (1979), p. 89400e.
Dodeur et al.-Chem. Abst., vol. 92 (1980), p. 191,157p.

Affiliated with

Also associated with

Rating

Method for treating cancer using galactose-specific lectins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating cancer using galactose-specific lectins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating cancer using galactose-specific lectins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-506083